We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Senate Panel Considers Changes To Pediatric Exclusivity
The item has been added to your shopping cart.
Senate Panel Considers Changes To Pediatric Exclusivity
March 30, 2007
As Congress considers reauthorization of two programs that encourage companies to gather information on drugs’ effects on children, witnesses at a recent hearing suggested improvements and debated the six months of exclusivity granted to manufacturers under one of the acts.